Natera Inc (NTRA)
Natera - Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer
Natera - Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer
Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
Johnson & Johnson - Johnson & Johnson SubmitsOTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product
SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call